Nipah spreads through contact with infected bats or contaminated fruit and can transmit between humans via bodily fluids. The trials, supported by the European Vaccine Initiative, are scheduled to begin in April.

Credits: Unsplash; Author: Mufid Majnun;

The vaccine uses a modified measles platform carrying Nipah genetic material and showed safety and effectiveness in hamster trials. The vaccine candidate will undergo Phase 1 human trials in Belgium, testing safety in 60 participants. There is currently no specific treatment for the Nipah virus beyond supportive care.